261 related articles for article (PubMed ID: 6270227)
1. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.
Levy GA; Leibowitz JL; Edgington TS
J Exp Med; 1981 Oct; 154(4):1150-63. PubMed ID: 6270227
[TBL] [Abstract][Full Text] [Related]
2. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
[TBL] [Abstract][Full Text] [Related]
3. The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo.
Dindzans VJ; MacPhee PJ; Fung LS; Leibowitz JL; Levy GA
J Immunol; 1985 Dec; 135(6):4189-97. PubMed ID: 2999239
[TBL] [Abstract][Full Text] [Related]
4. Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.
Fingerote RJ; Abecassis M; Phillips MJ; Rao YS; Cole EH; Leibowitz J; Levy GA
J Virol; 1996 Jul; 70(7):4275-82. PubMed ID: 8676449
[TBL] [Abstract][Full Text] [Related]
5. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
[TBL] [Abstract][Full Text] [Related]
6. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo.
Chung S; Gorczynski R; Cruz B; Fingerote R; Skamene E; Perlman S; Leibowitz J; Fung L; Flowers M; Levy G
Immunology; 1994 Nov; 83(3):353-61. PubMed ID: 7835959
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection.
Li C; Fung LS; Chung S; Crow A; Myers-Mason N; Phillips MJ; Leibowitz JL; Cole E; Ottaway CA; Levy G
J Exp Med; 1992 Sep; 176(3):689-97. PubMed ID: 1324969
[TBL] [Abstract][Full Text] [Related]
8. Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro.
Chung S; Sinclair S; Leibowitz J; Skamene E; Fung LS; Levy G
J Immunol; 1991 Jan; 146(1):271-8. PubMed ID: 1701794
[TBL] [Abstract][Full Text] [Related]
9. Treatment of resistant A/J mice with methylprednisolone (MP) results in loss of resistance to murine hepatitis strain 3 (MHV-3) and induction of macrophage procoagulant activity (PCA).
Fingerote RJ; Leibowitz JL; Rao YS; Levy GA
Adv Exp Med Biol; 1995; 380():89-94. PubMed ID: 8830551
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H-2-linked genes.
Dindzans VJ; Skamene E; Levy GA
J Immunol; 1986 Oct; 137(7):2355-60. PubMed ID: 3020124
[TBL] [Abstract][Full Text] [Related]
11. Activation of the immune coagulation system by murine hepatitis virus strain 3.
Levy G; Abecassis M
Rev Infect Dis; 1989; 11 Suppl 4(Suppl 4):S712-21. PubMed ID: 2546245
[TBL] [Abstract][Full Text] [Related]
12. Role of macrophage procoagulant activity in mouse hepatitis virus (MHV) infection: studies using T cell MHV-3 clones and monoclonal antibody 3D4.3.
Chung S; Li C; Fung LS; Crow A; Gorczynski R; Cole E; Perlman S; Leibowitz J; Levy G
Adv Exp Med Biol; 1993; 342():377-84. PubMed ID: 8209757
[No Abstract] [Full Text] [Related]
13. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
Liu MF; Ning Q; Pope M; Mosmann T; Leibowitz J; Ding JW; Fung LS; Rotstein O; Gorczynski R; Levy GA
Adv Exp Med Biol; 1998; 440():415-23. PubMed ID: 9782309
[TBL] [Abstract][Full Text] [Related]
14. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.
Pope M; Rotstein O; Cole E; Sinclair S; Parr R; Cruz B; Fingerote R; Chung S; Gorczynski R; Fung L
J Virol; 1995 Sep; 69(9):5252-60. PubMed ID: 7636967
[TBL] [Abstract][Full Text] [Related]
15. Effect of alterations in early signal transduction events on the induction of procoagulant activity by murine hepatitis virus strain 3 in vitro.
Chung SW; Rotstein OD; Downey GP; Levy GA
J Gen Virol; 1995 May; 76 ( Pt 5)():1181-7. PubMed ID: 7730802
[TBL] [Abstract][Full Text] [Related]
16. T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts.
Khanolkar A; Fulton RB; Epping LL; Pham NL; Tifrea D; Varga SM; Harty JT
J Immunol; 2010 Jul; 185(2):1132-41. PubMed ID: 20554960
[TBL] [Abstract][Full Text] [Related]
17. 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.
Abecassis M; Falk JA; Makowka L; Dindzans VJ; Falk RE; Levy GA
J Clin Invest; 1987 Sep; 80(3):881-9. PubMed ID: 3624490
[TBL] [Abstract][Full Text] [Related]
18. Virus specificity of the antiviral state induced by IFN gamma correlates with resistance to MHV 3 infection.
Mello IG; Vassão RC; Pereira CA
Arch Virol; 1993; 132(3-4):281-9. PubMed ID: 7691047
[TBL] [Abstract][Full Text] [Related]
19. Characterization of accessory cell function during acute infection of BALB/cByJ mice with mouse hepatitis virus (MHV), strain JHM.
de Souza MS; Smith AL
Lab Anim Sci; 1991 Apr; 41(2):112-8. PubMed ID: 1658437
[TBL] [Abstract][Full Text] [Related]
20. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
